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Background: All-trans retinoic acid (ATRA) is a natural vitamin A derivative that has a profound effect on
the regulation of cell growth, differentiation and death.
Aim: To investigate the tissue dynamic and cellular invasion effects of ATRA in choriocarcinoma (CCA), an
aggressive trophoblastic tumour, by using a three-dimensional organotypic culture model system and cell
invasion assay, respectively.
Methods: An organotypic culture model of two CCA cell lines, JAR and JEG, was established. The effects of
1 mM ATRA on proliferation, differentiation and apoptosis on this CCA model were assessed by
morphological assessment of the mitotic and apoptotic figures as well as by Ki-67 and caspase-related
M30 cytoDeath antibody immunohistochemistry and the terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick end labelling (TUNEL) assay. The effect of ATRA on p53 and its regulated
protein product, WAF1/Cip1, was also evaluated with DO7 and p21WAF1 antibodies, respectively.
Moreover, the effect of ATRA on cellular (CCA) invasion was also investigated with Cell Invasion Kit on the
JEG cell line.
Results: ATRA was found to induce marked apoptosis in organotypic cultures of both cell lines, as
evidenced by increased M30-positive cells (p,0.0001) and increased TUNEL-positive cells (p,0.0001) in
treated cultures; to decrease proliferation, as evidenced by decreased Ki-67-positive cells (p,0.0001);
and to decrease p53-DO7 immunoreactivity (p,0.0001) and increase p21WAF1 (p,0.0001)
immunoreactivity. 1.5 mM ATRA was found to effectively inhibit JEG cell invasion in the cell invasion assay.
Conclusion: ATRA treatment was found to inhibit invasion and proliferation and enhance apoptosis,
probably by the activation of caspases and induction of differentiation. ATRA and synthetic retinoids may
be alternative agents for the treatment of CCA.
C
horiocarcinoma (CCA), a highly invasive neoplasm, is a
member of gestational trophoblastic disease (GTD) and
is characterised by a bilaminar population of cytotro-
phoblasts and syncytiotrophoblasts, with an absence of
chorionic villuses.1 2 In this malignant condition, the neo-
plastic trophoblasts continue to invade and grow without
restraint, resulting in highly vascularised metastasis to
organs such as the lungs, brain and liver, and with poor
prognosis,3–6 especially in the pre-chemotherapy era.
All-trans retinoic acid (ATRA) is one of the naturally
occurring vitamin A derivatives,7 which can be obtained from
the diet as preformed retinoids from animal sources and as
provitamin carotenoids from plant sources. Vitamin A plays
an important part in the maintenance of normal growth,
reproduction and cell membrane integrity, mediated through
nuclear receptors.7 The activated nuclear receptors control the
expression of genes that regulate cell differentiation and
growth and the induction of apoptosis. In animals, vitamin A
deficiency has been associated with a higher incidence of
cancer and increased susceptibility to chemical carcinogens.7
Although the role of retinoids and receptors in GTD is
unknown, some early studies have suggested that vitamin A
deficiency carries a higher risk of GTD.8 Our previous studies
have also shown that the rates of proliferation and apoptosis
as well as the patterns of expression of oncogenes, tumour
suppressor genes, cathepsin D, tissue inhibitor of metallo-
proteinases and telomerase have a role in the pathogenesis of
GTD.9–19 This study aimed at investigating the effects of ATRA
on CCA through effects on cellular response, including
proliferation, apoptosis, cell cycle arrest and cell invasion.
To conduct experiments in an environment that best reflects
the biologically relevant situation, a three-dimensional
organotypic cell culture model was adopted. Organotypic
culture allows more vivid in vivo representations of tissue, as
intercellular interactions and interactions between the cell
and extracellular matrix exist. Such interactions are known
to influence gene expression and thus the constitution and
behaviour of cells.
MATERIALS AND METHODS
Cell culture
Two human CCA cell lines, JAR and JEG, were obtained from
the American Type Culture Collection (Manassas, Virginia,
USA). The two cell lines were maintained as monolayer in
modified Eagle’s medium supplemented with 10% fetal
bovine serum and antibiotics. All cell lines were kept under
sterile condition at 37 C˚ in a humidified atmosphere of 95%
air and 5% CO2.
ATRA preparation
ATRA was purchased from Sigma (Sigma Chemical
Company, St Louis, Missouri, USA). It was prepared just
before use in 100% ethanol and stored as aliquots of 10006
stocks at 220 C˚. The final concentration of ethanol was
0.001%, which was less than 0.01% and not toxic for cells. As
Abbreviations: ATRA, all-trans retinoic acid; CCA, choriocarcinoma;
GTD, gestational trophoblastic disease; TUNEL, terminal
deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick
end labelling
845
www.jclinpath.com
 on 1 March 2007 jcp.bmj.comDownloaded from 
ATRA is sensitive to light, all experiments were carried out in
subdued light and the tubes and culture plates containing
ATRA were covered with aluminium foil.
Organotypic cultures
Single-cell suspensions of the CCA cell lines were quantitated
with a haematocytometer. Volumes containing 105 cells were
centrifuged. The cell pellet was resuspended in a 4 C˚ solution
containing modified Eagle’s medium and 80% rat-tail
collagen I (Collaborative Biomedical Products, Bedford,
Massachusetts, USA). The suspension was poured into
Falcon cell culture inserts with transparent membranes
containing 0.4 mm pores (Becton Dickinson, Franklin Lakes,
New Jersey, USA), which were placed in tissue culture plates.
After the collagen was allowed to solidify, a layer of
36105 cells was placed on top of the collagen gels. The liquid
on top of the gel was allowed to evaporate and the medium
surrounding the insert was replenished every day. ATRA
treatment was started after 1 week of growth and replen-
ished with each change of medium. ATRA was administered
at the clinically achievable concentration, 1 mmol/l, by mixing
liquid drug stocks into the medium surrounding the insert.
Untreated control cultures were treated with the same
volume of ethanol used in ATRA treatments. After 1 week
of ATRA treatment, the collagen was wrapped in paper before
it was put it into a capsule for fixation; it was subsequently
embedded in paraffin-wax and sectioned. Sections from the
paraffin-wax-embedded blocks were stained with haematox-
ylin–eosin for histological evaluation. The experiments were
repeated in duplicate for each cell line.
Immunohistochemical analysis of M30 cytoDeath, p53
DO-7, Ki-67 and p21WAF1
The immunohistochemical analysis for M30, DO7, Ki-67 and
p21WAF1 was carried out, after antigen retrieval by micro-
wave, by using a streptavidin–biotin–peroxidase technique
(DAKO, Glostrup, Denmark).11 14 15 19 20 Briefly, formalin-
fixed, paraffin-wax-embedded sections (5 mm) were depar-
affinised and then immersed in 0.01 M citrate buffer (pH 6)
and irradiated in a microwave oven for 9 min at 750 W. The
sections were then treated with 3% hydrogen peroxide
(H2O2) and 10% rabbit serum to eliminate endogenous
peroxidase activity and non-specific binding, respectively.
Four antibodies, including monoclonal mouse anti-human
Ki-67 antibody (Zymed Laboratories, San Francisco,
California, USA), M30 cytoDeath antibody (Boehringer
Mannheim, Mannheim, Germany), p21WAF1 antibody
(Calbiochem, SanDiego, California, USA) and p53 DO-7
antibody (DAKO) were applied at neat, 1:50, 1:30 and 1:50
dilutions, respectively, and incubated overnight at 4 C˚. A
biotinylated rabbit anti-mouse antibody (DAKO) was applied
at a 1:100 dilution. Colour development was carried out by
A B C
D E F
G H I
J K L
Figure 1 Organotypic cultures of the two choriocarcinoma cell lines, JAR (A–J) and JEG (K,L), were grown in the absence (A,C,E,G,I,K) or in the
presence (B,D,F,H,J,L) of 1 mM all-trans retinoic acid (ATRA) in the medium. The experiments were duplicated for each cell line. Sections (406
magnification) were stained with haematoxylin–eosin (A,B), Ki-67 (C,D), M30 (E,F), terminal deoxynucleotidyl transferase-mediated deoxyuridine
triphosphate nick end labelling (G,H), p53-DO7 (I,J) and p21WAF1 (K,L). An increase in apoptotic activity (B,F,H) and reduced proliferation rate (B,D) is
seen after ATRA treatment. Reduced p53-DO7 (J) and increased p21WAF1 (L) expression can also be observed.
846 Chiu, Feng, Benbrook, et al
www.jclinpath.com
 on 1 March 2007 jcp.bmj.comDownloaded from 
applying streptavidin–biotin–peroxidase, 3,39-diaminobenzi-
dine tetrahydrochloride and H2O2. Mayer’s haematoxylin was
used to counterstain the nuclei. The sections were then
dehydrated in alcohol, cleared in xylene and mounted.
Negative controls were prepared by replacing the first
antibody with TRIS-buffered saline, and a positive control
for each antibody was included. A case of hydatidiform mole
that was immunoreactive for the five antibodies was used as
a positive control in each batch of experiments.11 14 15 20 21
Terminal deoxynucleotidyl transferase-mediated
deoxyuridine triphosphate nick end labelling analysis
Sections were dewaxed in xylene and rehydrated in graded
concentrations of ethanol and then in distilled water.
Endogenous peroxidase activity was blocked by incubation
in 3% H2O2. The slides were then treated with 20 mg/ml
proteinase K in 10 mM TRIS (pH 7.2) for 15 min at 37 C˚ and
washed in TRIS-buffered saline. Apoptotic cells were detected
by terminal deoxynucleotidyl transferase-mediated deoxyur-
idine triphosphate nick end labelling (TUNEL) with the in
situ cell detection kit (Boehringer Mannheim), according to
the manufacturer’s instructions, with minor modifications.
Incorporated fluorescein-deoxyuridine triphosphate was
detected by anti-fluorescein antibody conjugated with
horse-radish peroxidase and subsequent colour development
with diaminobenzidine H2O2. Sections were counterstained
with Mayer’s haematoxylin, dehydrated in ethanol, cleared in
xylene and mounted.
Evaluation
Sections were examined at 406 magnification. Cells with
clear brown nuclear labelling were defined as positive. All
nuclei in the sections were counted. Immunoreactivity for Ki-
67, M30, p53-DO7, p21WAF1 and TUNEL index in each section
was scored and expressed as a percentage of positive nuclei
among total number of nuclei counted. In routine haematox-
ylin–eosin staining, nuclei that were shrunken or fragmented
as multiple small pieces of nuclear material in the cell or cell
cytoplasm that resides as a small dense segment without
nuclear material were identified as apoptotic figures, whereas
cells with chromosomes separating in metaphases were
identified as mitotic figures. Both mitotic and apoptotic
figures were scored and expressed as a percentage of total
number of nuclei counted.
Cell invasion assay
Invasion chambers (Chemicon International, Temecula,
California, USA) composed of 24-well culture plates and
inserts with an 8-mm pore polycarbonate filter coated with
ECMatrix were used to study the chemoinvasion of the JEG
cell line after ATRA treatment. Cells were first trypsinised,
centrifuged and resuspended at a density of 106 cells/ml in
the culture medium containing different concentrations of
ATRA (0, 1, 1.5 and 2 mmol/l). They were then seeded on to
the upper chambers of inserts. Lower chambers of the inserts
contained the same medium without ATRA. After 24 h of
incubation under standard culture conditions, the ECMatrix
gel layer and non-invading cells were removed by wiping
with a cotton swab. The invasive cells were then stained on
the lower surface of the membrane by dipping inserts on the
staining solution provided for 20 min before photographing
the cell under a light microscope. In addition, the invasive
cells on the lower surface of the membrane were quantified
at optical density 560 nm after dissolving the stained cells in
10% acetic acid. All the experiments were duplicated.
Statistical analysis
Data were statistically analysed with SPSS for Windows V.8.
Nominal data were analysed by the x2 test. Numerical data
were analysed by the Mann–Whitney U test and analysis of
variance, and p,0.05 was considered to be significant.
RESULTS
Effect of ATRA on morphological changes
Table 1 lists the effects of ATRA on the proliferative and
apoptotic activities in JEG and JAR CCA cell lines.
In the absence of ATRA treatment, mitotic figures were
found much more often in the sections of both cell lines JAR
and JEG. Apoptotic bodies, characterised as dark shrunken
nuclei and multiple small fragments of nuclear material
(fig 1B), were found much more often in ATRA-treated
organotypic culture from both cell lines. In the absence of
ATRA, apoptosis occurred predominantly in cells that were
located at the periphery of the colonies, whereas in the
presence of ATRA, apoptosis was observed at both the centre
and the periphery of the colonies (fig 1A,B). Before and after
ATRA treatment, the CCA cells were present as mononuclear
cells, with a moderate amount of cytoplasm and hyperchro-
matic nuclei, compatible with cytotrophoblasts.
Multinucleated cells resembling syncytiotrophoblasts were
not detected. Thus, no substantial morphological evidence of
differentiation was observed in either the JAR or the JEG cell
line, regardless of ATRA treatment.
Effects of ATRA on proliferative activity
Table 1 summarises the percentage of Ki-67-immunoreactive
cells (fig 1C,D) in the JAR and JEG cells before and after
ATRA application, as an assessment of cell proliferation.21 We
found a significant difference in the Ki-67 immunoreactivity
before and after ATRA treatment in both cell lines
(p,0.0001). The results suggest that ATRA significantly
inhibits the growth of CCA cell lines.
Effects of ATRA on apoptotic activity
The M30 cytoDeath antibody was used to identify early
changes in the cytoskeleton related to the action of caspase in
apoptosis, whereas the TUNEL technique was used to identify
the free 39-OH terminal of the fragmented DNA that is
formed as a result of DNA endonucleases. M30 and TUNEL
positivity was shown as distinct nuclear staining (fig 1E–H).
Table 1 Effects of ATRA on the proliferative and
apoptotic activities in the JEG and JAR choriocarcinoma
cell lines
JEG JAR
ATRA
Positive
(%) p Value
Positive
(%) p Value
Antibody
DO7 2 63.05 ,0.0001* 32.10 0.202
+ 46.51 29.89
p21 2 31.70 0.307 23.63 ,0.0001*
+ 33.58 39.88
Ki-67 2 54.78 ,0.0001* 58.83 ,0.0001*
+ 25.55 49.19
M30 2 15.24 ,0.0001* 11.59 ,0.0001*
+ 26.38 28.29
TUNEL 2 42.21 ,0.0001* 49.10 ,0.0001*
+ 55.45 64.54
Morphology
Mitotic figure 2 2.04 0.849 2.68 0.578
+ 1.94 1.81
Apoptotic
figure
2 6.70
0.409
7.77
0.175
+ 8.73 10.90
ATRA, all-trans retinoic acid; TUNEL, terminal deoxynucleotidyl
transferase-mediated deoxyuridine triphosphate nick end labelling.
+, presence; 2, absence.
*Significant results (p,0.05).
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The percentage of M30 cytoDeath-positive and TUNEL-
positive cells in both the JAR and JEG CCA cell lines induced
by ATRA increased significantly (p,0.0001) compared with
the sections of culture that did not have ATRA treatment
(table 1).
ATRA induces p53 expression in CCA cell l ines
p53-DO7 and p21WAF1 immunoreactivity was also shown as
distinct nuclear staining (fig 1I–L) in both the cell lines with
and without ATRA treatment. A decrease in p53-DO7-positive
cells and an increase in p21WAF1-immunoreactive cells was seen
after retinoid treatment in both cell lines (table 1). The
reduction in p53-DO7 expression and the increase in p21WAF1
expression reached significance in the JEG and JAR cell lines,
respectively (p,0.0001).
Effect of ATRA on cell invasion assay
Figure 2 shows the effect of ATRA, at concentrations ranging
from 0 to 2 mmol/l, on JEG cell invasion through polycarbo-
nate filter coated with ECMatrix. In the absence of ATRA
1.2
1.0
0.8
0.6
0.4
0.2
0.0
0.0 1.0 1.5 2.0
O
D
 5
60
nm
ATRA concentration (mM)
A B
C D
Figure 2 Pattern of penetration of ECMatrix basement membrane in JEG cells. A total of 0.46106 cells were seeded into the chamber and allowed to
invade towards 10% fetal bovine serum for 24 h in the absence or presence of all-trans retinoic acid (ATRA). The cells on the lower surface of the filters
were stained blue. ATRA concentrations used were (A) 0; (B) 1 mmol/l; (C) 1.5 mmol/l; and (D) 2 mmol/l. The invasive cells on the lower surface of the
membrane were quantified by optical density (OD) at 560 nm after dissolving the stained cells in 10% acetic acid. Values are presented as mean (SEM)
on the basis of experiments carried out in duplicate.
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treatment, JEG cells, which were stained deep blue, invaded
the lower surface of the filter (fig 2A). When the JEG cells
were treated with up to 1 mM ATRA, we found a marked
decrease in the JEG cell invasion (fig 2B). As ATRA
concentration reached 1.5 mmol/l, complete inhibition of
JEG cell invasion was achieved (fig 2C,D).
DISCUSSION
Induction of apoptosis and differentiation is an important
mechanism in cancer treatment. Recently, ATRAs have proved
to be effective in the treatment of acute promyelocytic
leukaemia.22 23 Retinoic acid analogues have shown promise in
chemoprevention of cancers of the breast, ovary, head and neck.
Retinoid acid and its receptors are essential for the growth
and development of the mammalian fetus and play a part in
trophoblast invasion, implantation and differentiation.24–26
Expression of receptor to retinoic acid has been shown in
clinical samples of CCA, and JEG-3, a human CCA cell line,
also produces active retinoids.27–30 In monolayer culture of a
CCA cell line, with the use of a 3-(4.5-dimethylthiazol-2-yl)-
2.5-diphenyltetrozoliumbromide-based cell proliferation
assay, it was shown that ATRA could inhibit cell proliferation
and enhance the effect of standard chemotherapeutic agents,
such as methotrexate or actinomycin D.27 Retinoids may thus
be useful in the treatment for trophoblastic malignancy,
including CCA. The mechanisms of the action of retinoic acid
in CCA, however, remain unclear.
This study examined the response of CCA to ATRA
treatment in a biologically relevant system. Monolayer
cultures of cells are not accurate representations of in vivo
tissue, because they lack the interactions among cells and
between cells and with the extracellular matrix in vivo. These
interactions influence the constitution and behaviour of
cells.31 In organotypic models of malignancies,32 33 cancer cells
are grown inside and on top of a collagen matrix and such
three-dimensional growth permits a representation of
tumours that have invaded stromal tissue. To the best of
our knowledge, we are the first to use a three-dimensional
organotypic culture model system to investigate the tissue
dynamic effects of ATRA in CCA.
The growth of a tumour is determined by a balance of cell
division and cell death.21 Rapidly growing tumours exhibit
higher mitotic indices and lower apoptotic indices, which, in
combination, usually correlate with aggressive behaviour and
poorer prognosis. In this study, immunohistochemical
studies clearly showed that ATRA decreased the mitotic
activity and increased the apoptotic activity. Morphologically,
although reduced mitotic figures and increased apoptotic
bodies were observed after ATRA treatment, the difference
did not reach statistical significance. One possible explana-
tion is that the morphological manifestations of mitotic or
apoptotic figures are the end result of a complicated cascade
of events, may only last for a short duration and may not be
sensitive enough to reach statistical significance as shown in
our immunohistochemical studies with proliferative and
apoptotic markers.
ATRA-induced apoptosis in CCA cultures was shown by
morphological changes and also by the M30 cytoDeath
antibody and the TUNEL assay. In recent years, proteolytic
cleavage of certain cellular proteins is a central biochemical
feature of apoptosis. One important group of proteolytic
enzymes has been identified as caspases.34 Cytokeratins, in
particular cytokeratin 18, which is cleaved by caspase 3 or
caspase 7,35 are affected in very early events of apoptosis. M30
cytoDeath can detect a specific formalin-resistant caspase
cleavage site within cytokeratin 18.20 In the present study, the
marked increase in M30-immunoreactive cells after ATRA
treatment suggested that activation of caspases may be
associated with ATRA-induced apoptosis in CCA cell lines.
We also investigated whether the ATRA-induced apoptosis
in CCA cell lines related to p53 pathway and cell cycle
progression. In our previous study on the issue of p53
mutation in GTD, only wild-type p53 protein was found to be
overexpressed in clinical samples of CCA by c-DNA-based
sequencing and immunohistochemical method.17 Expression
of p53 correlated with proliferative activity. In our present
study, p53-DO7-positive cells were reduced in both CCA cell
lines after ATRA treatment, although statistical significance
was shown only in the JEG cell line. A reduction in the Ki-67
proliferative index was also observed, suggesting that ATRA
inhibits proliferation of CCA cells in vitro. These findings
suggested that the decrease in p53 expression in CCA cell
lines after ATRA treatment may be related to the growth
inhibitory effect.
p21WAF1 is a cell cycle regulator and down-stream effector
of p53. Overexpression of p21WAF1 is usually associated with
an inhibition of cellular growth, cell differentiation and
senescence, as well as with terminal differentiation in various
cell lineages.36 Expression of p21WAF1 may be induced by
factors related to differentiation and growth arrest.37 We have
previously shown that p21WAF1 was expressed predominantly
in the differentiated syncytiotrophoblasts, but not in the
cytotrophoblasts.14 The JAR and JEG cell lines contain only
cytotrophoblastic cells and they retained an undifferentiated
morphology after ATRA treatment. Nevertheless, an increase
in p21WAF1 immunoreactivity could be shown in ATRA-
treated sections of both cell lines. Thus, although there was
no morphological induction of differentiation into syncytio-
trophoblasts after ATRA treatment, the overexpression of
p21WAF1 suggested the possible presence of subtle biochem-
ical differentiation that may occur before morphological
differentiation. This hypothesis was supported by previous
reports documenting the induction of giant-cell formation38
and the secretion of human chorionic gonadotropin, both
related to differentiation into syncytiotrophoblasts, after the
addition of retinoic acid.27 39 40
Little is known about the effect of ATRA in the invasive-
ness of CCA. Our results showed that ATRA can effectively
inhibit JEG cell invasion in the cell invasion chamber. The
mechanisms controlling CCA cell invasiveness are poorly
understood so far, but may be closely linked to protease
expression.41 42 In CCA cells, we have recently shown the
down regulation of E-cadherin or b-catenin43 and tissue
inhibitor of metalloproteinase-344 that may be implicated in
CCA invasion potential.
Retinoic acid may also affect CCA cells via its inhibitory
effect on leptin.45 The expression of leptin and leptin receptor
in both complete and partial mole as well as in CCA and
placental-site trophoblastic tumours are up regulated com-
pared with those in normal first trimester.46
In summary, our study shows that ATRA suppresses
invasion and proliferation, and induces apoptosis in CCA
cells in vitro, implicating the association of p53, p21WAF1 and
caspase pathways. Further studies on ATRA and ATRA
analogues should be conducted for clinical treatment of
CCA. Experiments may be necessary to further validate and
delineate the molecular response of CCA cells to ATRA.
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